KP-1212 is a synthetic nucleoside analogue that exerts antiviral activity by inducing lethal mutagenesis of the viral genome, thereby increasing mutation rates beyond viral viability thresholds, and has been shown to inhibit HIV growth, making it a valuable research compound for studying antiviral mechanisms, viral replication fidelity, and mutation-driven therapeutic strategies.